Global Healthcare Private Equity Report 2024 Copyright © 2024 Bain & Company, Inc. All rights reserved.This work is based on secondary market research, analysis of financial information available or provided to Bain & Company and a range of interviews with industry participants. Bain & Company has not independently verified any such information provided or available to Bain and makes no representation or warranty, express or implied, that such information is accurate or complete. Projected market and financial information, analyses and conclusions contained herein are based on the information described above and on Bain & Company’s judgment, and should not be construed as definitive forecasts or guarantees of future performance or results. The information and analysis herein does not constitute advice of any kind, is not intended to be used for investment purposes, and neither Bain & Company nor any of its subsidiaries or their respective officers, directors, shareholders, employees or agents accept any responsibility or liability with respect to the use of or reliance on any information or analysis contained in this document. This work is copyright Bain & Company and may not be published, transmitted, broadcast, copied, reproduced or reprinted in whole or in part without the explicit written permission of Bain & Company.1Global Healthcare Private Equity Report 2024ContentsHealthcare Private Equity Market 2023: Year in Review and Outlook . . . . . . . . . . . . 2Generative AI Will Transform Healthcare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12Healthcare IT Hits a Speed Bump . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17Life Sciences: Navigating Shifts in the Innovation, Regulatory, and Operational Terrains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24India’s Healthcare Industry Comes of Age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 312By Nirad Jain, Kara Murphy, Dmitry Podpolny, Franz-Robert Klingan, Vikram Kapur, and Alex BoultonMacroeconomic challenges have exacted a toll on healthcare buyouts, but green shoots in deal activity reflect the industry’s strong fundamentals .Healthcare Private Equity Market 2023: Year in Review and OutlookAt a Glance Investors continue trying to unlock liquidity and raise capital for healthcare deals, in a challenging fund-raising environment . Biopharma deals represent the biggest share of healthcare buyouts, while new modalities and innovative therapies such as GLP-1s transform the investment landscape . As investors look to diversify their Asia-Pacific buyout activity, India is viewed as a place to deploy healthcare capital at scale . Private equity investors continue to pursue healthcare IT deals, ...
